AAAAAA

   
Results: 1-14 |
Results: 14
Cofactors for HIV disease progression in a cohort of homosexual and bisexual men
Authors: Vittinghoff, E Hessol, NA Becchetti, P Fusaro, RE Holmberg, SD Buchbinder, SP
Citation: E. Vittinghoff et al., Cofactors for HIV disease progression in a cohort of homosexual and bisexual men, J ACQ IMM D, 27(3), 2001, pp. 308-314
Relative dominance of epitope-specific cytotoxic T-lymphocyte responses inhuman immunodeficiency virus type 1-infected persons with shared HLA alleles
Authors: Day, CL Shea, AK Altfeld, MA Olson, DP Buchbinder, SP Hecht, FM Rosenberg, ES Walker, BD Kalams, SA
Citation: Cl. Day et al., Relative dominance of epitope-specific cytotoxic T-lymphocyte responses inhuman immunodeficiency virus type 1-infected persons with shared HLA alleles, J VIROLOGY, 75(14), 2001, pp. 6279-6291
Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression
Authors: Islam, SA Hay, CM Hartman, KE He, SQ Shea, AK Trocha, AK Dynan, MJ Reshamwala, N Buchbinder, SP Basgoz, NO Kalams, SA
Citation: Sa. Islam et al., Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression, J VIROLOGY, 75(10), 2001, pp. 4907-4911
Early human immunodeficiency virus (HIV) infection in the HIV network for prevention trials vaccine preparedness cohort: Risk behaviors, symptoms, and early plasma and genital tract virus load
Authors: Celum, CL Buchbinder, SP Donnell, D Douglas, JM Mayer, K Koblin, B Marmor, M Bozeman, S Grant, RM Flores, J Sheppard, HW
Citation: Cl. Celum et al., Early human immunodeficiency virus (HIV) infection in the HIV network for prevention trials vaccine preparedness cohort: Risk behaviors, symptoms, and early plasma and genital tract virus load, J INFEC DIS, 183(1), 2001, pp. 23-35
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study
Authors: Seage, GR Holte, SE Metzger, D Koblin, BA Gross, M Celum, C Marmor, M Woody, G Mayer, KH Stevens, C Judson, FN McKirnan, D Sheon, A Self, S Buchbinder, SP
Citation: Gr. Seage et al., Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study, AM J EPIDEM, 153(7), 2001, pp. 619-627
Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations
Authors: Gross, M Holte, S Seage, GR Buchbinder, SP Metzger, DS Mayer, KH
Citation: M. Gross et al., Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations, AIDS EDUC P, 12(1), 2000, pp. 71-78
Combination antiretroviral therapy and incidence of AIDS-related malignancies
Authors: Buchbinder, SP Holmberg, SD Scheer, S Colfax, G O'Malley, P Vittinghoff, E
Citation: Sp. Buchbinder et al., Combination antiretroviral therapy and incidence of AIDS-related malignancies, J ACQ IMM D, 21, 1999, pp. S23-S26
Correlates of condom failure in a sexually active cohort of men who have sex with men
Authors: Stone, E Heagerty, P Vittinghoff, E Douglas, JM Koblin, BA Mayer, KH Celum, CL Gross, M Woody, GE Marmor, M Seage, GR Buchbinder, SP
Citation: E. Stone et al., Correlates of condom failure in a sexually active cohort of men who have sex with men, J ACQ IMM D, 20(5), 1999, pp. 495-501
Use of reality "female condoms" for anal sex by US men who have sex with men
Authors: Gross, M Buchbinder, SP Holte, S Celum, CL Koblin, BA Douglas, JM
Citation: M. Gross et al., Use of reality "female condoms" for anal sex by US men who have sex with men, AM J PUB HE, 89(11), 1999, pp. 1739-1741
Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
Authors: Kalams, SA Buchbinder, SP Rosenberg, ES Billingsley, JM Colbert, DS Jones, NG Shea, AK Trocha, AK Walker, BD
Citation: Sa. Kalams et al., Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection, J VIROLOGY, 73(8), 1999, pp. 6715-6720
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors
Authors: Bradney, AP Scheer, S Crawford, JM Buchbinder, SP Montefiori, DC
Citation: Ap. Bradney et al., Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors, J INFEC DIS, 179(5), 1999, pp. 1264-1267
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality
Authors: Vittinghoff, E Scheer, S O'Malley, P Colfax, G Holmberg, SD Buchbinder, SP
Citation: E. Vittinghoff et al., Combination antiretroviral therapy and recent declines in AIDS incidence and mortality, J INFEC DIS, 179(3), 1999, pp. 717-720
Per-contact risk of human immunodeficiency virus transmission between malesexual partners
Authors: Vittinghoff, E Douglas, J Judson, F McKirnan, D MacQueen, K Buchbinder, SP
Citation: E. Vittinghoff et al., Per-contact risk of human immunodeficiency virus transmission between malesexual partners, AM J EPIDEM, 150(3), 1999, pp. 306-311
Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995
Authors: Koblin, BA van Benthem, BHB Buchbinder, SP Ren, L Vittinghoff, E Stevens, CE Coutinho, RA van Griensven, GJP
Citation: Ba. Koblin et al., Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995, AM J EPIDEM, 150(10), 1999, pp. 1026-1030
Risultati: 1-14 |